Biomedical/Medical Engineering at Rochester Institute of Technology

RIT's biomedical engineering program delivers stronger-than-expected outcomes at a manageable price point. Graduates start at $72,344—well above both the national and New York state medians—while carrying just $29,183 in debt. That 0.40 debt-to-earnings ratio means students can realistically pay off their loans in under five months of gross salary, one of the lowest burdens you'll find in this field nationally.

What makes this particularly attractive is the trajectory: earnings grow 14% to $82,443 within four years, matching the compensation at more selective private institutions like Rensselaer ($74,427 starting) and University of Rochester ($69,414). RIT ranks in the 82nd percentile nationally for earnings, though it sits at the 60th percentile among New York's biomedical programs—a reflection of the state's competitive landscape rather than any weakness in the program itself. The 71% admission rate makes this accessible to a broader range of students than you'd expect given these outcomes.

The moderate sample size means individual cohort variations could shift these numbers somewhat, but the fundamentals are solid: you're looking at strong starting salaries that keep climbing, minimal debt burden, and graduates who can afford to take the engineering jobs they actually want rather than ones dictated by loan payments. For families weighing RIT against pricier options, this represents excellent value.